rs5907

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PP3BP4_StrongBP6_Very_StrongBS2

The NM_000185.4(SERPIND1):​c.623G>A​(p.Arg208His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00175 in 1,614,202 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R208C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0015 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 3 hom. )

Consequence

SERPIND1
NM_000185.4 missense

Scores

6
9
4

Clinical Significance

Benign criteria provided, single submitter P:1B:1

Conservation

PhyloP100: 10.0

Publications

26 publications found
Variant links:
Genes affected
SERPIND1 (HGNC:4838): (serpin family D member 1) This gene belongs to the serpin gene superfamily. Serpins play roles in many processes including inflammation, blood clotting, and cancer metastasis. Members of this family have highly conserved secondary structures with a reactive center loop that interacts with the protease active site to inhibit protease activity. This gene encodes a plasma serine protease that functions as a thrombin and chymotrypsin inhibitor. The protein is activated by heparin, dermatan sulfate, and glycosaminoglycans. Allelic variations in this gene are associated with heparin cofactor II deficiency. [provided by RefSeq, Jul 2015]
PI4KA (HGNC:8983): (phosphatidylinositol 4-kinase alpha) This gene encodes a phosphatidylinositol (PI) 4-kinase which catalyzes the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate. The mammalian PI 4-kinases have been classified into two types, II and III, based on their molecular mass, and modulation by detergent and adenosine. The protein encoded by this gene is a type III enzyme that is not inhibited by adenosine. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Apr 2018]
PI4KA Gene-Disease associations (from GenCC):
  • polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: BayesDel_noAF, Cadd, Dann, Eigen, phyloP100way_vertebrate, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster, PROVEAN was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.050468773).
BP6
Variant 22-20779935-G-A is Benign according to our data. Variant chr22-20779935-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 14952.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 236 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SERPIND1NM_000185.4 linkc.623G>A p.Arg208His missense_variant Exon 2 of 5 ENST00000215727.10 NP_000176.2 P05546Q8IVC0
PI4KANM_058004.4 linkc.2328+13258C>T intron_variant Intron 19 of 54 ENST00000255882.11 NP_477352.3 P42356-1Q4LE69B4DYG5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SERPIND1ENST00000215727.10 linkc.623G>A p.Arg208His missense_variant Exon 2 of 5 1 NM_000185.4 ENSP00000215727.5 P05546
PI4KAENST00000255882.11 linkc.2328+13258C>T intron_variant Intron 19 of 54 1 NM_058004.4 ENSP00000255882.6 P42356-1

Frequencies

GnomAD3 genomes
AF:
0.00155
AC:
236
AN:
152194
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00405
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00238
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00138
AC:
346
AN:
251386
AF XY:
0.00138
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00273
Gnomad NFE exome
AF:
0.00225
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00177
AC:
2593
AN:
1461890
Hom.:
3
Cov.:
31
AF XY:
0.00170
AC XY:
1236
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33480
American (AMR)
AF:
0.000335
AC:
15
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000765
AC:
2
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86258
European-Finnish (FIN)
AF:
0.00286
AC:
153
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00211
AC:
2346
AN:
1112012
Other (OTH)
AF:
0.000977
AC:
59
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
151
302
453
604
755
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00155
AC:
236
AN:
152312
Hom.:
1
Cov.:
32
AF XY:
0.00176
AC XY:
131
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41562
American (AMR)
AF:
0.000850
AC:
13
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00405
AC:
43
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00238
AC:
162
AN:
68040
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00188
Hom.:
4
Bravo
AF:
0.00111
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00163
AC:
14
ExAC
AF:
0.00131
AC:
159
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00196
EpiControl
AF:
0.00172

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Heparin cofactor II deficiency Pathogenic:1Benign:1
Mar 25, 1989
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.50
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Pathogenic
0.43
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.41
T;T
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.86
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
.;D
M_CAP
Uncertain
0.092
D
MetaRNN
Benign
0.050
T;T
MetaSVM
Uncertain
0.27
D
MutationAssessor
Uncertain
2.6
M;M
PhyloP100
10
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-2.0
N;N
REVEL
Pathogenic
0.68
Sift
Uncertain
0.029
D;D
Sift4G
Uncertain
0.045
D;D
Polyphen
0.98
D;D
Vest4
0.85
MVP
0.96
MPC
0.64
ClinPred
0.18
T
GERP RS
6.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.72
gMVP
0.79
Mutation Taster
=6/94
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5907; hg19: chr22-21134223; COSMIC: COSV104551232; API